Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001567619-21-019331

EVP, Head of R&D sold 5,000 shares at $16.41 ($82,050)

  • EVP, Head of R&D acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Dupont Jakob EVP, Head of R&D 2021-11-02 Option exercise +5,000 $9.58 $47,900 97,793 D
Dupont Jakob EVP, Head of R&D 2021-11-02 Sale −5,000 $16.41 $82,050 92,793 D
Derivatives
Dupont Jakob EVP, Head of R&D 2021-11-02 Option exercise · Employee Stock Option (Right to Buy) −5,000 272,500 D
Open-market sales · 5,000 sh · avg $16.41 · $82,050
Loading xslF345X03/doc1.xml…